Daily Life Cardiac Ischaemia. Should It Be Treated?

Overview

Journal Drugs

Specialty Pharmacology

Date 1995 Feb 1

PMID 7729326

Authors

B D Bertolet

C J Pepine

Affiliations

Soon will be listed here.

Abstract

Daily life cardiac ischaemia is defined as reversible myocardial cellular hypoxia that occurs during activities of daily living, without artificial provocation. Most of these daily life ischaemic episodes are not associated with symptoms. However, it is not practical to distinguish silent versus symptomatic daily life ischaemia as both are associated with haemodynamic abnormalities and future adverse outcomes. Daily life cardiac ischaemia is best detected using ambulatory electrocardiogram (ECG) monitoring; however, there are other diagnostic tools (e.g. exercise treadmill) that can be used. Once detected, the optimal therapy for daily life myocardial ischaemia has yet to be identified. However, it does appear that usual antianginal medications including nitrates, beta-blockers, calcium antagonists and antiplatelet drugs are effective in reducing the incidence and severity of daily life myocardial ischaemia. Medical therapy and revascularisation should be utilised to obliterate all episodes of daily life cardiac ischaemia to prevent future cardiac events. Moreover, the efficacy of the chosen therapeutic regimen for each patient should be documented with follow-up objective testing. The diagnosis and management of daily life myocardial ischaemia is continually evolving. Future research as well as economic considerations will shape future management strategies.

References

Cohn P, Lawson W . Effects of long-acting propranolol on A.M. and P.M. peaks in silent myocardial ischemia. Am J Cardiol. 1989; 63(12):872-3. DOI: 10.1016/0002-9149(89)90061-1. View

Hill J, Gonzalez J, Kolb R, Pepine C . Effects of atenolol alone, nifedipine alone and their combination on ambulant myocardial ischemia. Am J Cardiol. 1991; 67(8):671-5. DOI: 10.1016/0002-9149(91)90519-q. View

NERI SERNERI G, Gensini G, Poggesi L, Trotta F, Modesti P, Boddi M . Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina. Lancet. 1990; 335(8690):615-8. DOI: 10.1016/0140-6736(90)90407-v. View

Stone P, Gibson R, Glasser S, DeWood M, Parker J, Kawanishi D . Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group. Circulation. 1990; 82(6):1962-72. DOI: 10.1161/01.cir.82.6.1962. View

Folts J, Stamler J, Loscalzo J . Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation. 1991; 83(6):2122-7. DOI: 10.1161/01.cir.83.6.2122. View

Pepine C, Cohn P, Deedwania P, Gibson R, Handberg E, Hill J . Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST). Circulation. 1994; 90(2):762-8. DOI: 10.1161/01.cir.90.2.762. View

Schneeweiss A, Marmor A . Transdermal nitroglycerin patches for silent myocardial ischemia during antianginal treatment. Am J Cardiol. 1988; 61(9):36E-38E. DOI: 10.1016/0002-9149(88)90088-4. View

Langer A, Minkowitz J, Dorian P, Casella L, Harris L, Morgan C . Pathophysiology and prognostic significance of Holter-detected ST segment depression after myocardial infarction. The Tissue Plasminogen Activator: Toronto (TPAT) Study Group. J Am Coll Cardiol. 1992; 20(6):1313-7. DOI: 10.1016/0735-1097(92)90242-f. View

Raby K, Barry J, Treasure C, Hirsowitz G, Fantasia G, Selwyn A . Usefulness of Holter monitoring for detecting myocardial ischemia in patients with nondiagnostic exercise treadmill test. Am J Cardiol. 1993; 72(12):889-93. DOI: 10.1016/0002-9149(93)91101-m. View

10.

Johnson S, Mauritson D, Corbett J, Woodward W, Willerson J, Hillis L . Double-blind, randomized, placebo-controlled comparison of propranolol and verapamil in the treatment of patients with stable angina pectoris. Am J Med. 1981; 71(3):443-51. DOI: 10.1016/0002-9343(81)90180-7. View

11.

Chirkov Y, Naujalis J, Barber S, Sage R, Gove D, Brealey J . Reversal of human platelet aggregation by low concentrations of nitroglycerin in vitro in normal subjects. Am J Cardiol. 1992; 70(7):802-6. DOI: 10.1016/0002-9149(92)90563-e. View

12.

Deligonul U, Vandormael M, Younis L, Chaitman B . Prognostic significance of silent myocardial ischemia detected by early treadmill exercise after coronary angioplasty. Am J Cardiol. 1989; 64(1):1-5. DOI: 10.1016/0002-9149(89)90643-7. View

13.

Levin R . Quantitation of transient myocardial ischemia by digital, ambulatory electrocardiography. Am J Cardiol. 1988; 61(3):13B-17B. DOI: 10.1016/0002-9149(88)91349-5. View

14.

Imperi G, Lambert C, Coy K, Lopez L, Pepine C . Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease. Am J Cardiol. 1987; 60(7):519-24. DOI: 10.1016/0002-9149(87)90297-9. View

15.

Distante A, Maseri A, Severi S, Biagini A, Chierchia S . Management of vasospastic angina at rest with continuous infusion of isosorbide dinitrate. A double crossover study in a coronary care unit. Am J Cardiol. 1979; 44(3):533-9. DOI: 10.1016/0002-9149(79)90408-9. View

16.

Mulcahy D, Keegan J, Cunningham D, Quyyumi A, Crean P, Park A . Circadian variation of total ischaemic burden and its alteration with anti-anginal agents. Lancet. 1988; 2(8614):755-9. DOI: 10.1016/s0140-6736(88)92414-2. View

17.

Fang Z, Picart N, Abramowicz M, Unger P, Narracci P, Sobolski J . Intravenous diltiazem versus nitroglycerin for silent and symptomatic myocardial ischemia in unstable angina pectoris. Am J Cardiol. 1991; 68(12):42C-46C. DOI: 10.1016/0002-9149(91)90222-7. View

18.

Bertolet B, Boyette A, Hofmann C, Pepine C, Hill J . Prevalence of pseudoischemic ST-segment changes during ambulatory electrocardiographic monitoring. Am J Cardiol. 1992; 70(7):818-20. DOI: 10.1016/0002-9149(92)90569-k. View

19.

Nabel E, Barry J, Rocco M, Mead K, Selwyn A . Effects of dosing intervals on the development of tolerance to high dose transdermal nitroglycerin. Am J Cardiol. 1989; 63(11):663-9. DOI: 10.1016/0002-9149(89)90248-8. View

20.

Schang Jr S, Pepine C . Transient asymptomatic S-T segment depression during daily activity. Am J Cardiol. 1977; 39(3):396-402. DOI: 10.1016/s0002-9149(77)80095-7. View